Harvard has granted a license to Aldatu Biosciences, a Cambridge-based startup, for a genotyping platform to address drug resistance in HIV patients. David Raiser (left), Ph.D.'15, and Iain MacLeod, a researcher at the Harvard Chan School, co-founded Aldatu in 2014.